Skip to main content
. 2009 Nov 6;9(3):579–592. doi: 10.1074/mcp.M900439-MCP200

Fig. 5.

Fig. 5.

CID-MS3 analysis in neutral loss scan mode for HSA glycated peptide identified in plasma. Two neutral losses were monitored: 162.05 and 84.04 Da corresponding to glucose cleavage and an intermolecular rearrangement of the glucose moiety, respectively.